PROCTER & GAMBLE HEALTH L Intrinsic Value
PGHL · Healthcare · Current price ₹6,799.5
Is PROCTER & GAMBLE HEALTH L undervalued?
DocStoX estimates the fair value of PROCTER & GAMBLE HEALTH L at ₹1,846 per share, versus the current market price of ₹6,800. That puts the stock about -72.8% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹687), Relative P/E (₹4,634), Graham floor (₹1,002). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹687 (bear) to ₹1,846 (base) to ₹4,634 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹6,800 versus an intrinsic value of ₹1,846, PROCTER & GAMBLE HEALTH L currently offers -72.8% of negative margin (i.e. a premium).
More on PROCTER & GAMBLE HEALTH L
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.